193 related articles for article (PubMed ID: 31579634)
1. Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy.
Shahid W; Kumar R; Shaikh A; Kumar S; Jameel R; Fareed S
Cureus; 2019 Jul; 11(7):e5293. PubMed ID: 31579634
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain.
Shah I; Ahmad W; Islam M; Jan B; Ul Haq E; Mahmood J; Iqbal N; Shah M
Cureus; 2022 Sep; 14(9):e28683. PubMed ID: 36199645
[TBL] [Abstract][Full Text] [Related]
3. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial-BLOSSOM.
Rakusa M; Marolt I; Stevic Z; Rebrina SV; Milenkovic T; Stepien A
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513930
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
7. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparative study of methylcobalamin, methylcobalamin plus pregabalin and methylcobalamin plus duloxetine in patients of painful diabetic neuropathy.
Sharma C; Kaur I; Singh H; Grover IS; Singh J
Indian J Pharmacol; 2021; 53(5):358-363. PubMed ID: 34854403
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy.
Devi P; Madhu K; Ganapathy B; Sarma G; John L; Kulkarni C
Indian J Pharmacol; 2012 Jan; 44(1):51-6. PubMed ID: 22345870
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin.
Enomoto H; Yasuda H; Nishiyori A; Fujikoshi S; Furukawa M; Ishida M; Takahashi M; Tsuji T; Yoshikawa A; Alev L
J Pain Res; 2018; 11():1857-1868. PubMed ID: 30271191
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
13. A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy.
Khasbage S; Shukla R; Sharma P; Singh S
J Diabetes; 2021 Jul; 13(7):532-541. PubMed ID: 33340245
[TBL] [Abstract][Full Text] [Related]
14. Fixed dose combination of low dose pregabalin and duloxetine, or pregabalin monotherapy for neuropathic pain: A double-blind, randomized, parallel-group study.
K K; Dutt S; Rattan P; Dadhania A; Gupta R; Joshi D; Kakkad A; Makwana A; Jha P
F1000Res; 2023; 12():353. PubMed ID: 38618021
[No Abstract] [Full Text] [Related]
15. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial.
Mu Y; Liu X; Li Q; Chen K; Liu Y; Lv X; Xu X; Fan D; Shang N; Yang R; Pauer L; Pan C
J Diabetes; 2018 Mar; 10(3):256-265. PubMed ID: 28727270
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of pregabalin for treating pain associated with diabetic peripheral neuropathy in subjects with type 1 or type 2 diabetes mellitus.
Parsons B; Li C; Emir B; Vinik AI
Curr Med Res Opin; 2018 Nov; 34(11):2015-2022. PubMed ID: 30084288
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
20. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial.
Barohn RJ; Gajewski B; Pasnoor M; Brown A; Herbelin LL; Kimminau KS; Mudaranthakam DP; Jawdat O; Dimachkie MM; ; Iyadurai S; Stino A; Kissel J; Pascuzzi R; Brannagan T; Wicklund M; Ahmed A; Walk D; Smith G; Quan D; Heitzman D; Tobon A; Ladha S; Wolfe G; Pulley M; Hayat G; Li Y; Thaisetthawatkul P; Lewis R; Biliciler S; Sharma K; Salajegheh K; Trivedi J; Mallonee W; Burns T; Jacoby M; Bril V; Vu T; Ramchandren S; Bazant M; Austin S; Karam C; Hussain Y; Kutz C; Twydell P; Scelsa S; Kushlaf H; Wymer J; Hehir M; Kolb N; Ralph J; Barboi A; Verma N; Ahmed M; Memon A; Saperstein D; Lou JS; Swenson A; Cash T
JAMA Neurol; 2021 Jan; 78(1):68-76. PubMed ID: 32809014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
